Efficacy of CS-758, a Novel Triazole, against Experimental Fluconazole-Resistant Oropharyngeal Candidiasis in Mice

The therapeutic efficacy of CS-758, a novel triazole, was evaluated against experimental murine oropharyngeal candidiasis induced by Candida albicans with various susceptibilities to fluconazole. Against infections induced by strains with various susceptibilities to fluconazole, the efficacy of fluc...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Kamai, Yasuki, Kubota, Mikie, Fukuoka, Takashi, Kamai, Yoko, Maeda, Naoyuki, Hosokawa, Tsunemichi, Shibayama, Takahiro, Uchida, Katsuhisa, Yamaguchi, Hideyo, Kuwahara, Shogo
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2003
Assuntos:	Experimental Therapeutics
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC151753/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12543666/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.47.2.601-606.2003
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!